Colgate-Palmolive's 15min chart signals bearish MACD and KDJ crossover.
ByAinvest
Thursday, Oct 2, 2025 10:18 am ET1min read
CL--
The MACD (Moving Average Convergence Divergence) and KDJ (Kaufman Adaptive Moving Average) are technical indicators used by traders to identify changes in the direction of a stock's price. A MACD Death Cross occurs when the MACD line crosses below the signal line, signaling a potential reversal to the downside. Similarly, a KDJ Death Cross happens when the KDJ line crosses below the K line, also indicating a potential downtrend.
Investors should closely monitor Colgate-Palmolive's stock price and other technical indicators to assess the validity of these signals. Historical data shows that such crosses can be followed by significant price movements, although they are not always reliable predictors.
Colgate-Palmolive's recent financial performance has been strong, with the company reporting better-than-expected earnings and a quarterly dividend of $0.52 per share, yielding 2.6%. Despite this positive financial news, the technical indicators suggest that investors may need to be cautious about the stock's future performance.
Institutional investors have also shown interest in Colgate-Palmolive, with several funds recently increasing their stakes in the company. J. Safra Sarasin Holding AG, for instance, reduced its holdings by 16.6% during Q2, but still owns approximately $66.65 million worth of shares [2]. Other institutional investors, such as Westend Capital Management LLC and Cornerstone Planning Group LLC, have also significantly increased their holdings in the first quarter.
Analysts have provided mixed ratings for Colgate-Palmolive, with some setting "buy" ratings and others setting "hold" or "underweight" ratings. The stock currently has an average rating of "Moderate Buy" and an average price target of $97.73 [1].
Investors should consider these technical indicators alongside Colgate-Palmolive's financial performance and analyst ratings when making investment decisions. The stock's recent technical shifts suggest a potential downward trend, but further analysis is needed to confirm this trend and assess the potential impact on the stock's price.
Colgate-Palmolive's 15-minute chart has triggered a MACD Death Cross and KDJ Death Cross at 10:15 on 02/10/2025, indicating that the stock price may continue to decline. This suggests a shift in momentum towards the downside, with potential further decreases in stock price.
Colgate-Palmolive's (NYSE:CL) stock experienced a significant technical shift on February 10, 2025, with the MACD and KDJ indicators signaling a potential downturn. At 10:15, the 15-minute chart triggered a MACD Death Cross and KDJ Death Cross, suggesting that the stock price may continue to decline. This shift in momentum indicates a potential further decrease in the stock's value.The MACD (Moving Average Convergence Divergence) and KDJ (Kaufman Adaptive Moving Average) are technical indicators used by traders to identify changes in the direction of a stock's price. A MACD Death Cross occurs when the MACD line crosses below the signal line, signaling a potential reversal to the downside. Similarly, a KDJ Death Cross happens when the KDJ line crosses below the K line, also indicating a potential downtrend.
Investors should closely monitor Colgate-Palmolive's stock price and other technical indicators to assess the validity of these signals. Historical data shows that such crosses can be followed by significant price movements, although they are not always reliable predictors.
Colgate-Palmolive's recent financial performance has been strong, with the company reporting better-than-expected earnings and a quarterly dividend of $0.52 per share, yielding 2.6%. Despite this positive financial news, the technical indicators suggest that investors may need to be cautious about the stock's future performance.
Institutional investors have also shown interest in Colgate-Palmolive, with several funds recently increasing their stakes in the company. J. Safra Sarasin Holding AG, for instance, reduced its holdings by 16.6% during Q2, but still owns approximately $66.65 million worth of shares [2]. Other institutional investors, such as Westend Capital Management LLC and Cornerstone Planning Group LLC, have also significantly increased their holdings in the first quarter.
Analysts have provided mixed ratings for Colgate-Palmolive, with some setting "buy" ratings and others setting "hold" or "underweight" ratings. The stock currently has an average rating of "Moderate Buy" and an average price target of $97.73 [1].
Investors should consider these technical indicators alongside Colgate-Palmolive's financial performance and analyst ratings when making investment decisions. The stock's recent technical shifts suggest a potential downward trend, but further analysis is needed to confirm this trend and assess the potential impact on the stock's price.
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet